Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.

MLA

Matschke, Jakob, et al. “Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.” Frontiers in Neurology, vol. 13, June 2022, p. 908081. EBSCOhost, https://doi.org/10.3389/fneur.2022.908081.

APA

Matschke, J., Lahann, H., Krasemann, S., Altmeppen, H., Pfefferle, S., Galliciotti, G., Fitzek, A., Sperhake, J.-P., Ondruschka, B., Busch, M., Rotermund, N., Schulz, K., Lohr, C., Dottermusch, M., & Glatzel, M. (2022). Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls. Frontiers in Neurology, 13, 908081. https://doi.org/10.3389/fneur.2022.908081

Chicago

Matschke, Jakob, Henri Lahann, Susanne Krasemann, Hermann Altmeppen, Susanne Pfefferle, Giovanna Galliciotti, Antonia Fitzek, et al. 2022. “Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.” Frontiers in Neurology 13 (June): 908081. doi:10.3389/fneur.2022.908081.